The
road map to mass vaccination or Covid vaccination plan in India
Strategy
for Covid vaccine distribution or action plan of Indian government
Covid
19 immunisation plan in India
Once a Covid-19 vaccine becomes
available in India, how does the government go about immunising the population
(covid19 immunising plan in India) ?
Which groups should get the vaccine first and who should get it free? (India
covid vaccine plan)
Why is it important to get vaccinated against Covid-19?
Covid-19 is an infectious virus
that causes a variety of clinical manifestations with great difficulty. It was
not easy to predict who would be safe from it. Even young people are known to
be very sick or die, although not as often as the elderly. Because of this
unexpected nature, everyone should feel threatened and seek protection.
Environmental infections can provide varying degrees of immunity, based on the
variable viral load that different people are exposed to.
We do not know how long the
immune system lasts in each person. The vaccine controls a moderate dose that
allows for a good immune response, which is likely to last longer than the
natural infection of flexible and acute viral infections. For that reason, vaccination
is a good idea. In addition, some countries will not allow an uninfected person
to travel there if the virus is still active. Employers who do not allow
unprotected employees to enter the workplace.
Which
age groups should get it first or who will get vaccine first?
The two main criteria for
selecting the first groups to be given the vaccine are also important and at
risk. These approaches are prominent in some groups. For example, health care
providers who test, monitor, treat or advise people with Covid-19 are both
providers of essential services and are at risk of infection. They will be the
most important thing everywhere. Other important activities include sanitation,
security, transportation and those involved in the production of essential
goods and services.
Applying the condition of risk,
the elderly and people with joint problems that increase the risk of serious
illness or death are priorities. Existing health problems that increase such
risk include high blood pressure, heart disease, diabetes, obesity, chronic
obstructive pulmonary disease, malnutrition and any other condition in which
the immune system is reduced by disease or drugs.
The problem with identifying
this group is that a number of people with these conditions may not be aware of
them, because weak health services in urban slums, small towns or valleys have
not tested or evaluated themselves. In such cases, it is best to use the age
requirement as a possible prediction and continue steadily down ten years from
the 60+ age group to the 20+ age group. The new person makes an exciting
challenge.
They are important for current
economic activities or need to pursue education, which is an investment for
future economic growth and growth. They are more susceptible to the virus
because of their high mobility and fun. While at low risk of severe infection,
they can infect others, especially older family members. Are they prioritized
for vaccinations or are they priorities? Opinions are divided. It also depends
on the number of vaccines available. If a limited number is found initially,
older groups will take precedence and a number of younger people will need to
wait.
How
prepared is India to carry out a mass vaccination campaign (vaccination in India)?
This depends on the vaccine
available. We will be able to choose from a set of safe and effective vaccines
that do not have the strict requirements for cold temperatures below zero
storage and transportation. Some effective vaccines will need to be stored at
only 2 ° –8 ° C or kept at room
temperature. If we can achieve that, the delivery of our assets will not create
problems in the early stages where clearly designated groups will be vaccinated.
As our supply chain expanded to
cover the community, we would have gained information and would be able to
manage the high numbers to come later, with greater efficiency. A major
challenge will be the actual administration of the vaccine, as intramuscular
injection in two set sets aside 3-4 weeks. Those currently not authorized to
administer such injections are doctors, nurses, and assisted midwives. Because
of our previous neglect, their numbers are not enough in most places. Those in
attendance will be busy providing other health services, including care for
people with Covid-19 infection.
What
should be the geographic strategy for a programme of this scale?
There are important employees
and people at risk everywhere. It would be better to start with cities where
overcrowding is high, mass murder rates are high, risk factors such as air
pollution are severe and health services are strong. The experience gathered
there will be useful as the vaccination program goes to small towns and rural
areas. However, if there are hot spots of rapidly growing cases in any part of
the country, immediate vaccination of affected people should be carried out.
Who
should get the vaccine for free?
We believe all persons should
receive the vaccine free. Protecting people from this rapidly spreading infectious
disease is the prime example of what economists call a“ public good”. If a
person does not get vaccinated because it is unaffordable and gets infected,
other susceptible persons can be infected by this person even as they await
their turn. Whether it is the government or employers paying for it, access to
the vaccine should not carry a cost to any individual. Since the private sector
healthcare providers too will get involved in delivering the vaccine at some
stage to supplement government agencies, financial mechanisms need to be worked
out to ensure that individuals are not subjected to out-of-pocket expenses
(vaccine for Indian public).
How
many phases of vaccination may be required?
However some people may wish to
count epidemic waves or vaccination stages, we see the vaccine drive go through
significant changes as it changes. Initially, the provision of our health
system will be limited as the production of any vaccine will be determined by
global demand. That is also the time when we will be applying the principle of
importance and starting the learning curve of our drug delivery system. The
number of vaccines will be very small and the effort will be easy as the number
of people who will be vaccinated is counted. That will move later to the stage
where the supply of the drug will be greater, both due to the wide range of
vaccines that get regulated authorization and the amount of production that
increases from the original vaccines by outsourced practice.
The domestic demand for
vaccines will also increase as confidence in the vaccine increases, as initial
international and national knowledge indicates safety. At this time,
vulnerability will be an important measure of priority, but the general public
can also be covered aside, age by group of years. The health system would also
go to great lengths to deliver the vaccine, with existing health workers added
by trained assistants.
However, listing and sequencing
more people will be a difficult task. Going forward, we will move towards a
stable situation where a limited number of people have been vaccinated and
vaccination work for all becomes part of the general health immunization
program. The increased response capacity will need to be maintained as a fixed
location at this stage, but both the supply and demand side pressures would be
reduced.
What
do we still not know about the way the government is preparing to vaccinate the
population?
Detailed plans may be made that the government has not yet disclosed. We do not yet know which vaccine to start with. We do not even know what guarantees there are to get shares from producers in advance. Is there a pre-purchase commitment made? If so many vaccines are available, what will be your preferred method of administration? If more vaccines are available, how will they be distributed in all provinces?
Despite the announcement that
health workers, other service providers and people with associated illnesses
would be prioritized, the public launch program was not disclosed. Procurement
will be coordinated by the central government. How will the need for each state
be addressed, in different stages? At what stage, can provinces buy directly
from producers? If so, will the center provide quality and cost guidelines to
ensure complete consistency? Do other segments of the population have to pay?
If so, what would the price be? There is no information on the proposed role of
private health care providers, pharmacists and employers in the planned field
of immunization program. How can they support the government's plan (government
action plan for covid vaccine)?
How
long ,realistically ,will it take for life to get back to normal?
It depends on how the virus behaves in the coming year, how the vaccine starts and how it could unite the world in the coming months. Will the virus become smaller or more infected? We do not know. Will the vaccine pass all control checks to arrive soon? It seems possible but there is a western need to see the final data for the case. Until next year, we will need to actively seek public health advice on masks, exercise, hand washing and avoiding the most common events. The arrival of summer can give us rest but not fully relax. Therefore, if 2020 is a year of despair and despair, 2021 should be a year of morality and determination to defeat the virus with all the tools we are collecting or making now.